SCHEMBL646690

SCHEMBL646690

CN(Cc1cccc(F)c1)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.48
MAOA P21397 2/20 0.40
MAOB P27338 2/20 0.40
CASP3 P42574 2/20 0.40
ALDH1A1 P00352 2/20 0.37
ALDH1A3 P47895 1/20 0.37
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
RORC P51449 2/20 0.35
NAMPT P43490 1/20 0.35
TP53 P04637 2/20 0.35
PTGER1 P34995 1/20 0.34
LMNA P02545 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PER2 O15055 1/20 0.33
CRY1 Q16526 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL647188 0.92 HSP90AA1 (0.52) HSP90AA1MAOAMAOBCASP3ALDH1A1
SCHEMBL646733 0.91 HSP90AA1 (0.45) HSP90AA1MAOAMAOBCASP3ALDH1A1
SCHEMBL647209 0.91 HSP90AA1 (0.49) HSP90AA1MAOAMAOBCASP3TP53
SCHEMBL644619 0.91 HSP90AA1 (0.49) HSP90AA1ALDH1A1RORCTP53LMNA
SCHEMBL646245 0.91 HSP90AA1 (0.49) HSP90AA1ALDH1A1RORCTP53PTGER1
SCHEMBL646966 0.91 HSP90AA1 (0.52) HSP90AA1ALDH1A1TP53LMNARXFP1
SCHEMBL646667 0.88 HSP90AA1 (0.51) HSP90AA1ALDH1A1TP53LMNARXFP1
SCHEMBL644542 0.87 HSP90AA1 (0.49) HSP90AA1ALDH1A1RORCLMNARXFP1
SCHEMBL645541 0.87 HSP90AA1 (0.51) HSP90AA1RORCTP53LMNARXFP1
SCHEMBL646372 0.87 HSP90AA1 (0.50) HSP90AA1ALDH1A1NAMPTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885MAOA 3267/4885MAOB 3057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.